PI
BPMC

PEAK6 Investments’s Blueprint Medicines BPMC Stock Holding History

PEAK6 Investments’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.93M Buy
+20,893
New +$2.08M ﹤0.01% 1531
2024
Q2 		– Sell
-4,710
Closed -$471K – 3597
2024
Q1 		$447K Sell
4,710
-6,979
-60% -$599K ﹤0.01% 2523
2023
Q4 		$1.08M Buy
11,689
+6,794
+139% +$440K ﹤0.01% 2032
2023
Q3 		$246K Buy
+4,895
New +$262K ﹤0.01% 2933
2023
Q2 		– Sell
-4,201
Closed -$228K – 3956
2023
Q1 		$189K Buy
+4,201
New +$189K ﹤0.01% 3146

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PEAK6 Investments's BPMC Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Blueprint Medicines (BPMC) in Q3 2024: 20,893 shares worth $1.93M. The stake represents ﹤0.01% of the portfolio and ranks #1531 among its holdings. This is a return to the name: PEAK6 Investments previously reported a position in BPMC as recently as Q1 2024.

PEAK6 Investments first reported a position in BPMC in Q1 2023 and has held it in 5 quarters since. 319 funds tracked by Wall St. Rank hold BPMC as of Q3 2024.

  • PEAK6 Investments held 20,893 shares of Blueprint Medicines worth $1.93M as of Q3 2024.
  • Blueprint Medicines was a new PEAK6 Investments position in Q3 2024.
  • Blueprint Medicines made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1531 holding.
  • PEAK6 Investments first reported a position in Blueprint Medicines in Q1 2023 and has held it in 5 quarters since.
  • 319 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.